Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenylate kinase 4 pseudogene 5 (AK4P5) is a genomic DNA sequence in humans that shares homology with the adenylate kinase 4 (AK4) gene but is classified as a pseudogene, meaning it does not encode a functional protein. Pseudogenes typically arise from duplication or retrotransposition events but lose coding potential due to mutations or lack of necessary regulatory elements. AK4P5 has no established biological function, drug interactions, or clinical relevance as a biomarker or disease target. Its presence should not be confused with the closely related, functional AK4 gene (adenylate kinase 4), which encodes a mitochondrial enzyme involved in cellular energy metabolism[5][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenylate kinase 4 pseudogene 5 (AK4P5).